C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/16 (2006.01) A61K 38/35 (2006.01) C07K 14/575 (2006.01) C07K 14/695 (2006.01) C07K 16/26 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2470656
Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
L'invention concerne des dérivés isolés du facteur de libération de la corticotropine et des acides nucléiques codant pour ceux-ci, efficaces dans le traitement des troubles modulés par le récepteur du facteur 2 de libération de la corticotropine, tels que la dystrophie musculaire.
Isfort Robert Joseph
Mazur Wieslaw Adam
The Procter & Gamble Company
Torys Llp
Warner Chilcott Company Llc
LandOfFree
Corticotropin releasing factor 2 receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Corticotropin releasing factor 2 receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Corticotropin releasing factor 2 receptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2070194